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R4496Cϩ/Ϫ . Whereas individual reduction of Ca 2ϩ release channel of SR and Na-Ca exchanger up to 50% was ineffective, 30% or more reduction of either I Ca,L or IUP could totally suppress the inducibility of arrhythmia under BAS. Of note, 15% reduction of both I Ca,L and IUP exerted a synergistic antiarrhythmic efficacy. Findings of this model study confirm that BAS facilitates induction of ventricular tachyarrhythmias via its action on intracellular Ca 2ϩ cycling and a pharmacological regimen capable of reducing I Ca,L could be an effective adjunctive to ␤-adrenergic blockers for suppressing ventricular tachyarrhythmias during CPVT. computational modeling; delayed afterdepolarizations; store-overload-induced Ca 2ϩ release; triggered activity CATECHOLAMINERGIC POLYMORPHIC ventricular tachycardia (CPVT) is an inherited arrhythmogenic disorder characterized by episodic syncope occurring during physical activity or acute emotional distress in individuals without structural heart disease and ECG abnormalities (21, 23) . Characteristically, episodes of syncope are usually related to the occurrence of bidirectional or polymorphic ventricular tachycardia that might degenerate into ventricular fibrillation. In ϳ60% of CPVT patients, molecular genetic studies have unfolded that mutations are mostly located in the gene encoding the cardiac ryanodine receptor (RyR2; autosomal dominant) and rarely in the gene encoding calsequestrin (CASQ2; autosomal recessive) in the sarcoplasmic reticulum (SR) (23) . By age of 40, cardiac events occur in 80% of patients and the mortality rate could be as high as 30 -50% (23) . Clinical observations have shown that ␤-adrenergic blocking agents provide only incomplete protection and other antiarrhythmic agents such as quinidine, verapamil, and amiodarone are either ineffective or only partially efficacious (18, 19, 21, 23, 28) . Of note, some patients need to resort to implantation of implantable cardioverter/defibrillators (ICD) and/or left cardiac sympathetic denervation and even to cardiac transplantation (23, 39) .
Although more than 70 RyR2 mutations have been identified, mechanisms by which RyR2 mutations alter the properties of RyR2 thereby generating ventricular tachyarrhythmias in CPVT remain highly debatable (23) . The three major ones speculated include reduced affinity of calstabin2 (FKBP12.6) to RyR2, defective interdomain interaction within RyR2, and increased Ca 2ϩ sensitivity of RyR2. Regardless of the exact underlying mechanism, the general consensus is that RyR2 mutations lead to abnormally augmented Ca 2ϩ release, which results in the genesis of delayed afterdepolarizations (DADs) and DAD-mediated triggered activity (TA), underpinning the development of ventricular tachyarrhythmias (23) .
In attempts to elucidate electrophysiological mechanisms of ventricular tachyarrhythmias, few investigators have performed computational modeling of CPVT mutations. Using a human left ventricular epicardial myocyte model, Iyer and Armoundas (14) reduced the buffering capacity for Ca 2ϩ alongside acceleration of adaptation transition in SR to simulate CASQ2 mutations and decreased the cooperability of RyR2 for enhancing its open probability to simulate RyR2 mutations; upon ␤-adrenergic stimulation (BAS), they could induce DADs in both CASQ2 and RyR2 mutants but not in wild-type. Applying a Luo-Rudy dynamic (LRd) ventricular myocyte model, which had incorporated dynamics of intracellular Ca 2ϩ cycling (8, 9), Faber and Rudy (9) simulated the ventricular myocyte expressing homozygous CASQ2 D307H mutation with 60% reduction of the total Ca 2ϩ binding capacity of CASQ2; they illustrated that rapid pacing under BAS increased myocyte Ca 2ϩ loading, culminating in spontaneous SR Ca 2ϩ release followed by development of DADs. In the present study, we adopted the same LRd ventricular myocyte model (8, 9) to simulate RyR2 R4496C mutation (15, 23) , in which mouse phenotype closely resembled clinical manifesta-tions of CPVT patients with RyR2 R4497C mutation (2, 3, 10, 22) . Our goals were to further define the role of BAS in the arrhythmogenesis of RyR2 R4496C mutation with attendant gain-of-function (23) and, more importantly, to search for potential targeted sites involved in the dynamics of intracellular Ca 2ϩ cycling for effective suppression of ventricular tachyarrhythmias associated with CPVT.
METHODS
Single LRd cell model. We used the LRd ventricular myocyte model, which had incorporated interacting Markov models of the L-type Ca 2ϩ channel (ICa,L) and RyR2 in a restricted t-tubular subsarcolemmal space for Ca 2ϩ distribution (8, 9) . The heterogeneity of ion channels was expressed in three cell types of the ventricular myocyte, i.e., the density ratios between slow and rapid delayed rectifiers (GK s:GKr) were set at 23 ]jsr) were monitored. During BAS, transition rates were altered between states of ICa,L and parameters of other currents including the slow component of delayed rectifier (I Ks), Na-K pump (INaK), inward rectifier (IK1), and Iup were formulated such that changes of these parameters would reflect effects of a saturating concentration of isoproterenol at Ն0.1 M. All formulations and source program codes of above described modifications of the LRd model can be found in References 8 and 9.
Multicellular one-dimensional strand model. The transmural heterogeneity of ion channel densities was incorporated in a theoretical strand with a total length of 1.65 cm composed by 165 LRd model cells to represent Endo (1st to 60th), M (61th to 105th), and Epi (106th to 165th) cells interconnected by resistive gap junctions (11) . Barring a fivefold decrease in the gap junction coupling at the junction between M and Epi cells (103th to 107th cells), gap junction conductance was set to be homogeneous at 1.73 S or with a diffusion coefficient (D) ϭ 0.000766 cm 2 /ms throughout the strand as shown in the following monodomain equation:
where Vm is the transmembrane potential of the myocyte, D is the diffusion coefficient, Iion is the total sarcolemmal ion currents normalized by the capacitance, and Istim is the stimulus current. The resultant propagation velocity measured 50 cm/s and a conduction time of 33 ms. The pseudo-ECG was obtained as described by Gima and Rudy (11) .
Modeling of wild-type RyR2 myocyte (RyR2wt) and RyR2 R4496C mutant cells. In the process of formulation modifications, we first tried to fit into the cellular functional characteristics depicted by Jiang et al. (15) so that the R4496C mutant cell would exhibit enhanced sensitivity of RyR2 to luminal Ca 2ϩ . However, we realized that the cell systems used by Jiang et al. (15) were those of heterologous human embryonic kidney (HEK)293 cell lines devoid of complex cardiac intracellular environment. Therefore, secondly, we attempted to conform to cellular phenotypic manifestations of the RyR2 R4496C knock-in mouse model described by Liu et al. (22) Fig. 1C . Specifically, when compared with RyR2wt at baseline, there was a slight increase in the RyR2 activity associated with R4496C mutation, which then became more enhanced in response to an increase in luminal Ca 2ϩ concentrations. Hence, our results were comparable with experimental data obtained by Jiang et al. (15) .
Furthermore, to compare RyR2 activities between channel and cell scales, we simulated 1, 5, 50, 500, and 5,000 channels running for 2,500 ms. Results of 1, 50, and 5,000 channel simulations, as illustrated in Supplemental Figs. S1 and S2, supported that our simulated R4496C mutant could maintain the tendency of enhanced sensitivity to Ca 2ϩ from a single-channel scale to a cell scale (e.g., 5,000 channels).
Consequent to our modification of formulations affecting the gating properties of RyR2 and the mechanism of SOICR (I rel,SOICR), which included alteration of its threshold (i.e., 5.2 for the R4496C mutant and 8.4 for RyR2wt), we also could produce cellular phenotypic manifestations in close accord with those experimentally demonstrated by Liu et al. (22) in the R4496C knock-in mouse model. As illustrated in Fig. 2 , pacing for 64 stimuli was started at 1 Hz and then the pacing rate was increased to 2, 3, 4, and 5 Hz with 5-s intermission in between. Note pacing at 1, 2, and 3 Hz induced no DADs and DAD-mediated TA in both RyR2wt and RyR2
R4496Cϩ/Ϫ (Fig. 2 , A-C). In contrast, pacing at 4 Hz elicited one single DAD (hollow circle in Fig. 2D ) and pacing at 5 Hz elicited a sustained run of DAD-mediated TA (9 TA beats are shown with the first 1 denoted by a solid circle in Fig. 2E ) in RyR2
R4496Cϩ/Ϫ , but not in RyR2wt (not shown). Whereas BAS exerted no arrhythmogenic effect in RyR2wt, it facilitated induction DAD-mediated TA in RyR2
R4496Cϩ/Ϫ . For example, pacing for 50 stimuli at 5 Hz, either at control (without BAS) or under BAS, induced no arrhythmias in RyR2wt (Fig. 3A) , but it elicited one single DAD-mediated TA beat at control and a sustained run of DAD-mediated TA in RyR2
R4496Cϩ/Ϫ under BAS (10 TA beats are shown in Fig. 3B ).
Study protocols. Subsequently, we attempted to obtain steady state values of isolated Endo, M, and Epi cells (25) and used these values as initial data for single cell and strand simulation studies, the details of which were defined as follows:
With the assumption that S i was one of the values of peak [Na 2ϩ ]i, peak [Ca 2ϩ ]jsr, peak Vm, resting Vm (RMP), peak [Ca 2ϩ ]i, and resting [Ca 2ϩ ]i, during the ith beat, the steady state of a cell was deemed achieved if the following criteria were all satisfied for some consecutive 31 paced beats (i.e., for some n below):
where error ε ϭ 0.001 mM, 0.001 mM, 0.1 mV, 0.000001 mV, 0.00001 mM, 1e-12 mM for peak [Na 2ϩ ]i, peak [Ca 2ϩ ]jsr, peak Vm, resting V m (RMP), peak [Ca 2ϩ ]i, and resting [Ca 2ϩ ]i, respectively; Siϩ1 Ϫ S1 represented the variation between ith beat and (iϩ1)th beat of these values, and the criteria above meant that the average variation for 31 consecutive paced beats was less than the prescribed error ε. We applied these criteria to Endo, M, and Epi cells of RyR2wt and RyR2
R4496Cϩ/Ϫ without and with BAS in 12 settings. The error ε mentioned above was the average value, but in some cases, it could be less than the average. At 2 Hz, ϳ12 min of pacing was needed for R4496Cϩ/Ϫ cells so obtained are listed in Supplemental Table S1 . After steady state values of isolated Endo, M, and Epi cells had been obtained, action potential duration (APD) of various percentages of repolarization, e.g., 90% (APD 90) and 97% (APD97), was measured. To observe emergence of abnormal automaticity related to changes in the resting membrane potential (RMP) (e.g., that caused by I K1 reduction), we waited for 40 s in a resting state in both RyR2wt and RyR2
R4496Cϩ/Ϫ before further pacing (33) . To assess effects of BAS, electrical stimulation was delivered to test the inducibility of DADs, and DAD-mediated TA after steady state values of each cell type at 2 Hz had been used as initial data. To determine contribution of each element of BAS to arrhythmia induction, we assessed effects of removing I Ca,L, IK1, IKs, and IUP individually (34) . Based on the mode of induction of DADs, and DADmediated TA, potential targeted sites for antiarrhythmic therapy relating to intracellular Ca 2ϩ cycling-ICa,L, IUP, Irel, and Na-Ca exchanger (INaCa)-were each systematically decreased by 5% stepwise until 50% reduction was reached (34) . Given that INaK is strongly regulated by intracellular Na ϩ , which depends on the pacing rate, and that transient accommodation of Na is a slow process (25), we opted not to evaluate its removal effect.
Finally, to determine the role of the gap junction coupling in generating DADs and/or DAD-mediated TA in the strand configuration, we tested and adjusted the diffusion coefficient (D) (19, 25, 27) in the monodomain model depicted in Multicellular one-dimensional strand model (11) .
RESULTS

Correlation of [Ca 2ϩ ] i with induction of DADs and DADmediated TA. Dynamic changes of [Ca 2ϩ ] i of our simulated wild-type RyR2 and RyR2
R4496Cϩ/Ϫ cells were compared with experimental data obtained from the RyR2
R4496Cϩ/Ϫ knock-in mouse model (10) . Notably, the findings that the induction of DADs and DAD-mediated TA was dependent on the pacing rate and BAS (Figs. 2 and 3) were in agreement with those elegantly reported by Fernandez-Velasco et al. (10) R4496Cϩ/Ϫ cell (Supplemental Fig. S4 ), matching findings of Fig. 6, A and B R4496Cϩ/Ϫ at high pacing rates. However, in contrast with findings in the ventricular myocyte of the R4496C knock-in mouse model reported by Fernandez-Velasco et al. (Fig. 4, A and F ] jsr simultaneously increased rather than decreased as the pacing rate became faster, a phenomenon that has been referred to as positive staircase response (7) . We surmised that the latter phenomenon was related to the LRd model being based on guinea pig data (8, 9) .
Despite differences in animal species (e.g., mouse vs. guinea pig) and the study methodology (experiment vs. simulation), we also compared data on Ca 2ϩ transients of our model study with those of experiments done by Fernandez-Velasco et al. (Fig. 4A In A-C, pacing induced no delayed afterdepolarizations (DADs) or DAD-mediated triggered activity. In D, a single DAD is denoted by OE, and in E, the first of a run of 9 DAD-mediated triggered activity beats by . In each panel, the arrow points to the last pacing stimulus.
Effects of RyR2
R4496Cϩ/Ϫ on RMP, APD, and the QT interval. In either the single cell or one-dimensional strand model (Tables 1and 2) , simulated RyR2
R4496Cϩ/Ϫ did not cause any significant change in RMP at control (without BAS) (e.g., Ϫ88.9 and Ϫ88.9 mV for RyR2wt and RyR2
R4496Cϩ/Ϫ , respectively, in single M cell recordings at 2 Hz) and with BAS (e.g., Ϫ85 and Ϫ85 mV for RyR2wt and RyR2
R4496Cϩ/Ϫ , respectively, in single M cell recordings at 2 Hz). In single cell recordings, APD 90 R4496Cϩ/Ϫ (Supplemental Fig. S4 ), but not in RyR2wt. Further evidence of BAS facilitating induction of DAD-mediated TA is illustrated in Fig. 5 . ]i, RMP, and APD97 were obtained from the mid-myocardial cell (80th cell of the multicellular strand) of the 21st pseudo-ECG beat where QT interval was also measured at a pacing frequency of 2.0 Hz. (Fig. 5A) . However, under BAS, the stimulus (vertical arrow), which also captured the M cell, elicited a sustained run of DAD-mediated TA in RyR2
R4496Cϩ/Ϫ (10 TA beats are shown in Fig. 5B ), but not in RyR2wt (even no DADs were discernible).
Of note, when compared with RyR2wt, RyR2 R4496Cϩ/Ϫ had smaller systolic I rel due to effect of Ca 2ϩ -dependent inactivation, but had larger diastolic I rel because of enhanced open probability (see I rel plot of Fig. 5A R4496Cϩ/Ϫ up to 40%, the total conductance of I rel was too low to induce release of Ca 2ϩ for the generation of DADs and/or DAD-mediated TA. 
i corresponding to the M cell without BAS (C) and with BAS (D).
Note that similar to findings of the single cell study (Fig. 5, A and B Fig. 5B ) and thereby triggered onset of DADs/DAD-mediated TA (17) . Of note also, pacing did not induce DADs and/or DAD-mediated TA in RyR2wt at control and under BAS, because [Ca 2ϩ ] jsr of RyR2wt never attained the threshold value of 8.4 under both circumstances (Fig. 5, A and B) .
Generation of DAD-mediated TA under BAS among different cell types and role of gap junction coupling (diffusion current) in the RyR2
R4496Cϩ/Ϫ strand configuration. After having applied steady state values of isolated (Endo, M, and Epi) cell simulations as initial data for the strand model study, we noted that a critical range of gap junction coupling represented by the diffusion coefficient (D) was required for the generation of DADmediated TA in RyR2
R4496Cϩ 2 /ms" (red line), the emergence of DAD-mediated TA beats (n ϭ 6) occurred with very small diffusion currents. In contrast, in the case of "D ϭ 0.000766*99 cm 2 /ms" (black line), huge outward diffusion currents depicted as positive deflections prevented DADs (n ϭ 4) from becoming DADmediated TA beats. These findings implied that the diffusion current was an important contributing factor for the generation of DAD-mediated TA in this strand model study (19, 25, 27, 29) .
Secondly, when an I rel,SOICR -related event occurs to induce depolarization in a cell, its membrane potential would become higher than that of its neighboring cells. As a result, it would need to incur more outward diffusion current to reduce the spatial gradient of membrane potential, thereby exhibiting a suppressive effect on depolarization. Under this circumstance, the larger is the diffusion coefficient D, and the more marked is its suppressing effect on depolarization. Note the membrane potential in the setting of "D ϭ 0.000766*0.005 cm 2 /ms" is higher compared with that of "D ϭ 0.000766*99 cm 2 /ms" during both systolic and diastolic phases because of its having a smaller outward diffusion current as shown in Supplemental  Fig. S7 . With higher membrane potential, I Ca,L is stronger even in the resting phase (see inset of I Ca,L plot in Supplemental Fig.  S7 Supplemental Fig. S6 , it appeared that the ease with which DAD-mediated TA generation could be generated was in the order of the M cell first and then the Endo cell followed finally by the Epi cell. The mechanism by which the M cell was more susceptible than the other two cell types was due to its having less GK s :GK r , thereby manifesting a longer APD and a higher RMP (see inset of I Ca,L plot in Supplemental Fig. S7) ] jsr , and I UP plots in Supplemental Fig. S8B ), the latter of which then activated I rel,SOICR to generate DADs and DADmediated TA.
Contribution of each individual element of BAS on induction of DAD-mediated TA and potential targeted sites of antiarrhythmic therapy.
After steady state values under BAS at 2 Hz had been used as initial data, pacing for 421 stimuli in the M cell at 2.0 Hz was performed in RyR2
R4496Cϩ/Ϫ under full effects of BAS (top trace in Fig. 6) , and it induced a sustained run of DAD-mediated TA. This was compared with those under BAS with removal of individual element of I Ca,L , I K1 , I Ks , and I UP . Removal of I K1 was totally ineffective and removal of I Ks first accelerated the rate of DAD-mediated TA and then converted it to sustained DADs (3rd and 4th traces in Fig. 6 ). Notably, removal of I Ca,L totally prevented DADs and DAD-mediated TA from occurrence and removal of I UP slowed the rate of DAD-mediated TA and rendered it to become nonsustained (2nd and bottom traces in Fig. 6 ).
To identify potential targeted sites for effective pharmacotherapy, we paced the M cell of RyR2
R4496Cϩ/Ϫ for 422 stimuli at 2.0 Hz after steady state values under BAS at 2 Hz had been used as initial data. Under full BAS, it elicited a sustained run of DAD-mediated TA (top traces of a, b, c, and d in Fig. 7) . Reduction of I Ca,L or I UP to 30% or more was required to totally suppress inducibility of DADs and DAD-mediated TA (Fig. 7A) . Reduction of I rel (effects of 20% and 30% reduction are shown in Fig. 7B ) and up to 50% (not shown) exerted no antiarrhythmic efficacy and reduction of I NaCa accelerated DAD-mediated TA during pacing and then converted to sustained DADs activity.
The corresponding time course of [Ca 2ϩ ] jsr , I rel , and [Ca 2ϩ ] i evidently showed that reduction of either I Ca,L or I UP up to 30% could effectively prevent [Ca 2ϩ ] jsr to attain the threshold value of 5.2, thereby suppressing onset of DADs and DAD-mediated TA in RyR2
R4496Cϩ/Ϫ under BAS (Fig. 7A) . Because enhancement of both I Ca,L and I UP was crucial underlying BAS-facilitated induction of DADs and DAD-mediated TA (Fig. 6) , we examined effect of combined reduction of these two currents. As shown in Fig.  8 , reduction of both I Ca,L and I UP each by 15% exhibited a synergistic effect as it could totally suppress the inducibility of DADs and DAD-mediated TA in RyR2
R4496Cϩ/Ϫ in the presence of BAS.
DISCUSSION
With modeling of the RyR2 R4496C mutation using the LRd ventricular myocyte model (8, 9), we were able to simulate RyR2 mutant cells that could exhibit cellular functional properties as well as cellular phenotypic manifestations in close similarity to those described experimentally (10, 15, 22) , i.e., 1) enhanced sensitivity of RyR2 to luminal Ca 2ϩ (Fig. 1, A-C (23, 33, 34) , genesis of DADs and DAD-mediated TA was not associated with QT interval prolongation (Tables 1 and 2 and Fig. 4) ; and 5) BAS facilitated induction of DAD-mediated TA via enhancing both I Ca,L and I UP (Figs. 5 and 6 ). It is also noteworthy to note that the study demonstrated that 30% or more reduction of either I Ca,L or I UP was required to suppress the inducibility of BAS-enhanced arrhythmogenesis and that combined 15% reduction of both I Ca,L and I UP could exert a synergistic antiarrhythmic efficacy (Figs. 7 and 8) .
Experimentally, electrophysiological mechanisms of arrhythmogenesis in CPVT have been well elucidated over the past several years (2, 3, 10, 12, 16, 22) . Relevant to our modeling study, Cerrone et al. (2) showed that RyR2
R4496Cϩ/Ϫ knock-in mouse mice were prone to bidirectional ventricular tachycardia after exercise followed by epinephrine or caffeine administration and that the tachycardia could degenerate into ventricular fibrillation. Liu et al. (22) demonstrated that in RyR2
R4496Cϩ/Ϫ knock-in mouse mice, DADs, and/or DADmediated TA induced by pacing and/or isoproterenol could be abolished by ryanodine but not by K201(an agent that enhances binding of FKBP12.6 to RyR2). Using the technique of optical imaging, Fernandez-Velasco et al. (10) showed an increase in Ca 2ϩ sensitivity of RyR2 along with a lowered SOICR threshold in the cardiac myocyte isolated from the RyR2 R4496Cϩ/Ϫ knock-in mouse. Similarly, Kashimura et al. (16) confirmed that the RyR2 R4496Cϩ/Ϫ cell had lower SR Ca 2ϩ content and a lower SOICR threshold compared with the RyR2wt counterpart and that BAS-induced increase in SR Ca 2ϩ was sufficient to attain the SOICR threshold resulting in the production of Ca 2ϩ waves in the RyR2 R4496Cϩ/Ϫ but not in the RyR2wt cell. Results of our study are in agreement with observations made in these experimental studies.
That the M cell was more vulnerable than Endo and Epi cells to develop DADs and DAD-mediated TA is in accordance with what have been described in experimental and computer modeling studies (1, 9, 34) . However, the observation that the gap junction coupling represented by the diffusion coefficient D was crucial in the generation of DAD-mediated TA in the strand model is intriguing. In general, propagation of an action potential follows the source-sink relationship, depending on active and passive properties of individual elements of a conducting network (19, 27, 29) . Among various passive properties, gap junctions are essential for determining how much depolarizing current passes from excited to nonexcited regions of the network, with which the safety factor for conduction is defined as the ratio of charge generated for the fiber by cell excitation to the minimal amount of charge required to cause the excitation (19, 27) . Although the safety factor was not measured, findings of our study conform to the source-sink relationship. Specifically, under the setting of 0 Յ D Յ 0.000766*98 cm 2 /ms, a cell could exhibit a higher RMP than in the setting of D Ͼ 0.000766*98 cm 2 /ms due to its having less outward diffusion currents, thereby enabling DADs to attain the excitation threshold to manifest DAD-mediated TA (Supplemental Fig. S7 ). Given that there was a difference in D between the two regions: Endo-M and M-Epi (the latter of which had a preset 5-fold decrease in the gap junction coupling as described in METHODS), it became easier for DAD-mediated TA to transmit from the M cell to the Endo than to the Epi (Supplemental Fig. S6 ). Nevertheless, we realize that our study did not contain all the complexity of action potential propagation encountered in experiments such as specific cellular architecture, separate contribution of different ion currents, gap junction resistance, cell dimensions to propagation safety, etc. (19, 27) .
With regard to targeted sites for effective pharmacotherapy, recent experimental data and preliminary clinical observations are of interest (18, 26, 28) . In CASQ2 mutant mice, verapamil (a Ca 2ϩ -channel blocker) exhibited a dose-dependent protection against sympathetic stimulation-induced ventricular arrhythmia and its action was markedly enhanced when combined with propranolol (a ␤-blocker) (18) , and clinically, combination therapy by adding verapamil to a ␤-blocker seemed more effective than ␤-blocker therapy alone in preventing exercise-induced arrhythmias in a limited number of patients with CPVT (18, 28) . However, in a rat chronic heart failure model, SR Ca 2ϩ ATPase2a (SERCA2a) gene therapy restored SR Ca 2ϩ load and reduced RyR2 phosphorylation, thereby increasing the threshold of SOICR (without affecting the open probability of RyR2) and in turn decreased the SR Ca 2ϩ leak; consequently, SERCA2a gene therapy attenuated TA in vitro and catecholamine-sensitive ventricular arrhythmias in vivo in failing hearts (26) . Barring the complex action of I UP , its activity depends on [Ca 2ϩ ] i , and a balance between [Ca 2ϩ ] jsr and the ease with which Ca 2ϩ waves propagate determines whether any change in the I UP activity would be antiarrhythmic or proarrhythmic in each specific setting (37) . At present, all I UP blocking agents such as thapsigargin remain investigational and most of them exhibit extraneous side effects (5). Because BAS exerts its proarrhythmic effects through enhancement of both I Ca,L and I UP activities in RyR2
R4496Cϩ/Ϫ , it is no surprise to find that combined 15% reduction of both I Ca,L and I UP could synergistically suppress BAS-facilitated induction of DADs and DAD-mediated TA (Fig. 8B) .
Whereas Ca 2ϩ waves are produced by Ca 2ϩ release through RyR2, experimentally it is well appreciated that not all I rel channel inhibitors (e.g., tetracaine) can suppress Ca 2ϩ waves (37, 38) . Despite I NaCa involvement in the genesis of I Ti (17, 37) , serving as a trigger for the genesis of DADs and DADmediated TA, our simulation study demonstrated that up to 50% reduction of I NaCa failed to prevent arrhythmia from occurrence under BAS (Fig. 7) . Finally, although reduction of I NaK was not tested because of slow accommodation of intracellular Na ϩ (25), we anticipated that I NaK reduction would increase cytosolic Na ϩ and thereby elevate [Ca 2ϩ ] i via the reverse mode I NaCa ; elevation of [Ca 2ϩ ] i would then lead to an increase in [Ca 2ϩ ] jsr thereby causing SR Ca 2ϩ overload (17, 30) and triggering I rel,SOICR events. Hence, I NaK inhibitors such as digitalis should be deemed contraindicated in patients with CPVT (30) .
Clinical implications. CPVT is a malignant arrhythmogenic disorder that predisposes the young with normal cardiac structure to syncope and cardiac arrest (21, 23) . Our study has demonstrated the ease with which BAS facilitates induction of DADs and/or DAD-mediated TA. Although most patients are benefited by taking ␤-blockers, many of them continue to experience arrhythmic spells and are impervious to therapy with other antiarrhythmic drugs (18, 19, 21, 23, 28) . Similar to patients with Timothy syndrome (LQT8) (34) , ICD therapy may cause repeated delivery of electrical shocks (electrical storm) due to first shock-induced activation of sympathetic tone. Consequently, it is worthwhile to explore an additional or alternative therapeutic potential. To that end, our study has suggested that a regimen capable of reducing I Ca,L and/or I UP might be a useful adjunctive to ␤-adrenergic blocking agents and/or ICD implantation for suppressing ventricular tachyarrhythmias associated with CPVT.
Recently, it has been reported that flecainide inhibits Ca 2ϩ waves by blocking the open state of RyR2 and might thus be useful for suppressing ventricular arrhythmias in CPVT patients (13, 36, 38) . Also experimentally in RyR2
R4496Cϩ/Ϫ knock-in mice, CaMK protein kinase II (CaMKII) overexpression enhances RyR2 phosphorylation and thereby increases the propensity toward triggered ventricular arrhythmias accounting for increased mortality (6) . On the other hand, CaMKII inhibition counteracts with effects of BAS and thereby prevents arrhythmias in the ventricular myocyte of RyR2 R4496Cϩ/Ϫ knock-in mice (24) . Thus research endeavors targeting at specific sites in the dynamics of intracellular Ca 2ϩ cycling appear promising for treating patients with CPVT.
Limitations. Data obtained in the present study should be interpreted with caution. Besides inherent limitations of the computer modeling, precise correlation cannot always be achieved due to difference in species (e.g., mouse vs. guinea pig) and the study methodology (experiment vs. model simulation). While a common pathway (23) for RyR2 and CASQ2 mutations is yet to be proved, findings described herein might not be applicable to CPVT patients due to CASQ2 mutations, those due to RyR2 mutations caused by dysfunctional FKBP12.6 or defective interdomain interaction (23, 40) and those due to mutations other than RyR2 and CASQ2 that have yet to be determined.
Currently, for testing of a specific pharmacological agent, besides inclusion of ion channels Markov scheme (4), the recently described multiscale modeling linking ion channel molecular dynamics and electrostatics to the cardiac action potential (31) may confer more in-depth systematic information. Nevertheless, theoretical observations made in a simulation study as exemplified herein can provide potential directions for basic experiments and for clinical trials in inherited arrhythmogenic disorders (34) . Similarly, it can be further anticipated that the field of medical modeling will have an important role in studying various clinical conditions with acquired dysfunction of intracellular Ca 2ϩ cycling such as myocardial ischemia and congestive heart failure.
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